ENZO BIOCHEM INC Quarterly Share-based Payment Arrangement, Expense in USD from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Enzo Biochem Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q4 2011 to Q3 2024.
  • Enzo Biochem Inc Share-based Payment Arrangement, Expense for the quarter ending October 31, 2024 was $171K, a 84.1% decline year-over-year.
  • Enzo Biochem Inc annual Share-based Payment Arrangement, Expense for 2023 was $2.27M, a 51.6% increase from 2022.
  • Enzo Biochem Inc annual Share-based Payment Arrangement, Expense for 2022 was $1.5M, a 64.9% increase from 2021.
  • Enzo Biochem Inc annual Share-based Payment Arrangement, Expense for 2021 was $907K, a 2.79% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $171K -$904K -84.1% Aug 1, 2024 Oct 31, 2024 10-Q 2024-12-16
Q1 2024 $2.69M $207K -$281K -57.6% Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-13
Q4 2023 $2.97M $261K -$174K -40% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-13
Q3 2023 $3.15M $1.08M +$877K +443% Aug 1, 2023 Oct 31, 2023 10-Q 2024-12-16
Q2 2023 $2.27M $1.15M +$708K +161% May 1, 2023 Jul 31, 2023 10-K 2023-11-03
Q1 2023 $1.56M $488K +$326K +201% Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-13
Q4 2022 $1.23M $435K -$244K -35.9% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-13
Q3 2022 $1.48M $198K -$18K -8.33% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-15
Q2 2022 $1.5M $439K +$172K +64.4% May 1, 2022 Jul 31, 2022 10-K 2023-11-03
Q1 2022 $1.32M $162K -$135K -45.5% Feb 1, 2022 Apr 30, 2022 10-Q 2022-06-09
Q4 2021 $1.46M $679K +$503K +286% Nov 1, 2021 Jan 31, 2022 10-Q 2022-03-14
Q3 2021 $956K $216K +$49K +29.3% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-12
Q2 2021 $907K $267K +$62K +30.2% May 1, 2021 Jul 31, 2021 10-K 2022-10-14
Q1 2021 $845K $297K +$90K +43.5% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-09
Q4 2020 $755K $176K -$126K -41.7% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-14
Q3 2020 $881K $167K -$52K -23.7% Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-15
Q2 2020 $933K $205K +$83K +68% May 1, 2020 Jul 31, 2020 10-K 2022-10-14
Q1 2020 $850K $207K -$84K -28.9% Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-11
Q4 2019 $934K $302K +$11K +3.78% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-16
Q3 2019 $923K $219K -$16K -6.81% Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-11
Q2 2019 $939K $122K May 1, 2019 Jul 31, 2019 10-K 2021-10-12
Q1 2019 $291K +$87K +42.6% Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-09
Q4 2018 $291K +$83K +39.9% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-06
Q3 2018 $235K +$30K +14.6% Aug 1, 2018 Oct 31, 2018 10-Q 2019-12-10
Q1 2018 $204K -$5K -2.39% Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-10
Q4 2017 $208K -$33K -13.7% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-11
Q3 2017 $205K +$54K +35.8% Aug 1, 2017 Oct 31, 2017 10-Q 2018-12-10
Q1 2017 $209K +$60K +40.3% Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-11
Q4 2016 $241K +$131K +119% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-12
Q3 2016 $151K +$40K +36% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-07
Q1 2016 $149K +$36K +31.9% Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-08
Q4 2015 $110K +$5K +4.76% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-13
Q3 2015 $111K +$13K +13.3% Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-08
Q1 2015 $113K -$170K -60.1% Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-08
Q4 2014 $105K -$4K -3.67% Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-09
Q3 2014 $98K -$5K -4.85% Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-08
Q1 2014 $283K +$143K +102% Feb 1, 2014 Apr 30, 2014 10-Q 2015-06-09
Q4 2013 $109K -$51K -31.9% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-12
Q3 2013 $103K -$39K -27.5% Aug 1, 2013 Oct 31, 2013 10-Q 2014-12-09
Q1 2013 $140K -$28K -16.7% Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-09
Q4 2012 $160K -$57K -26.3% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-11
Q3 2012 $142K Aug 1, 2012 Oct 31, 2012 10-Q 2013-12-10
Q1 2012 $168K Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-10
Q4 2011 $217K Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.